glp-1 effect on muscle mass Weight loss with medicines does not result in a disproportionate loss of or function in obese mice and humans Muscle Loss with GLP-1 Medications:

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells

These two Tyr residues in turn form pi-pi interactions

(Medicare Policy Initiative) FDA approvals matter: When a GLP-1 drug gains an FDA label for something like reducing heart attack risk (beyond weight loss), that opens up possible Medicare Part D coverage for that use

Effect of Metformin on Insulin Resistance in Adults with Type 1 Diabetes: A 26-week Randomized Double-blind Clinical Trial

Conversely, UC is limited to the mucosal layer of the colon and rectum ( A considerable number of patients with IBD fail to achieve durable clinical remission

2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD